Editorial: Prophylactic efficacy and safety of COVID-19 vaccines in preventing disease caused by various SARS CoV-2 variants

Front Cell Infect Microbiol. 2024 Mar 13:14:1384601. doi: 10.3389/fcimb.2024.1384601. eCollection 2024.
No abstract available

Keywords: COVID-19; SARS-CoV-2; complications; prevention; prophylaxis; vaccination.

Publication types

  • Editorial

MeSH terms

  • COVID-19 Vaccines* / therapeutic use
  • COVID-19* / prevention & control
  • Humans
  • SARS-CoV-2*

Substances

  • COVID-19 Vaccines

Supplementary concepts

  • SARS-CoV-2 variants

Grants and funding

The author(s) declare that no financial support was received for the research, authorship, and/or publication of this article.